Filtros de búsqueda

Lista de obras de

223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice.

artículo científico publicado en 2017

68Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients

artículo científico publicado en 2020

A Systematic Review of the Use of Social Media for Dissemination of Clinical Practice Guidelines

artículo científico publicado en 2020

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

artículo científico publicado en 2011

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics

artículo científico publicado en 2019

A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or “insignificant”

artículo científico publicado en 2008

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

artículo científico publicado en 2012

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.

artículo científico

Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.

artículo científico publicado en 2010

Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions

artículo científico publicado en 2016

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

artículo científico publicado en 2019

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy

artículo científico publicado en 2009

CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.

artículo científico publicado en 2014

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the Netherlands.

artículo científico publicado en 2013

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

artículo científico publicado en 2014

Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.

artículo científico

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

artículo científico publicado en 2013

Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes

artículo científico publicado en 2015

Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model

artículo científico publicado en 2017

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

artículo científico publicado en 2003

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.

artículo científico publicado en 2016

Development and Validation of A Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Metastatic Castration-Resistant Prostate Cancer Patients.

artículo científico publicado en 2018

Difficulties in pain management using oxycodone and fentanyl in enzalutamide-treated patients with advanced prostate cancer

artículo científico publicado en 2017

Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial

scientific article published on 03 May 2015

Does the Tertiary Gleason Pattern Influence the PSA Progression-Free Interval after Retropubic Radical Prostatectomy for Organ-Confined Prostate Cancer?

artículo científico publicado en 2005

Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

artículo científico publicado en 2017

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients

artículo científico publicado en 2018

Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology

scientific article published on 30 September 2020

Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer

artículo científico publicado en 2013

Fear of cancer recurrence in prostate cancer survivors.

artículo científico publicado en 2016

Fear of cancer recurrence: a significant concern among partners of prostate cancer survivors

artículo científico publicado en 2017

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

artículo científico publicado en 2010

Genetic correction of PSA values using sequence variants associated with PSA levels

artículo científico publicado en 2010

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

artículo científico publicado en 2009

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospect

scientific article published on 23 November 2018

Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands

artículo científico publicado en 2019

High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility

scientific article published on 02 June 2019

Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer

artículo científico publicado en 2015

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors

scientific article published on 14 November 2018

Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer

scientific article published on 23 September 2020

Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer

artículo científico publicado en 2020

Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategy

artículo científico publicado en 2019

Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series

artículo científico publicado en 2012

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative

scientific article published on 05 July 2019

KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment

artículo científico publicado en 2014

Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer

scientific article published on 05 January 2015

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

scientific article published on 14 September 2020

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen

artículo científico publicado en 2009

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.

artículo científico publicado en 2008

Nationwide treatment patterns and survival of older patients with prostate cancer

artículo científico publicado en 2018

Novel use of Twitter to disseminate and evaluate adherence to clinical guidelines by the European Association of Urology.

artículo científico publicado en 2017

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting

artículo científico publicado en 2019

POSITIVE MARGINS AFTER RADICAL PROSTATECTOMY, DOES NUMBER OF MARGINS AND SITE MATTER?

PREDICT: model for prediction of survival in localized prostate cancer.

artículo científico publicado en 2015

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives

artículo científico publicado en 2018

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide

artículo científico publicado en 2016

Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer

artículo científico publicado en 2014

Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey

artículo científico publicado en 2014

Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review

artículo científico publicado en 2014

Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation

artículo científico publicado en 2015

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy

artículo científico publicado en 2011

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

artículo científico publicado en 2012

Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer

artículo científico publicado en 2012

Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.

artículo científico publicado en 2011

Prostate cancer biomarker profiles in urinary sediments and exosomes.

artículo científico publicado en 2013

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

artículo científico

Quality of life after prostate cancer treatments in patients comparable at baseline.

artículo científico publicado en 2013

Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy

artículo científico publicado en 2011

Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group

scientific article published on 25 March 2019

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry

scientific article published on 07 October 2019

Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer

artículo científico publicado en 2020

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

artículo científico publicado en 2011

Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme

scholarly article by Axel Heidenreich et al published 31 January 2014 in European Journal of Cancer

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands

artículo científico publicado en 2019

Self-reported acne is not associated with prostate cancer

artículo científico publicado en 2014

Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling

artículo científico

THE CORRELATION BETWEEN THE LENGTH OF POSITIVE SURGICAL MARGINS AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER

The Combination of Enzalutamide and Opioids: A Painful Pitfall?

scientific article published on 21 September 2018

The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer

artículo científico publicado en 2017

The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited

artículo científico publicado en 2016

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

artículo científico publicado en 2019

The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients

artículo científico publicado en 2020

The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy.

artículo científico publicado en 2010

The oncologic role of local treatment in primary metastatic prostate cancer

artículo científico publicado en 2014

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

artículo científico publicado en 2013

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system

scientific article published on 11 March 2008

The prognostic value of E-cadherin and the cadherin-associated molecules α-, β-, γ-catenin and p120ctn in prostate cancer specific survival: A long-term follow-up study

artículo científico publicado en 2007

Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry

artículo científico publicado en 2020

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

artículo científico publicado en 2008

Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands

artículo científico publicado en 2012

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study

artículo científico publicado en 2014

Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI.

artículo científico publicado en 2013

Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.

artículo científico publicado en 2012

Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up

artículo científico publicado en 2018

Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study

scientific article published on 17 November 2019

[Multiparametric MRI for prostate cancer screening]

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda